Key Points
The Supreme Court weighs a pivotal Purdue Pharma settlement shielding the Sackler family from opioid crisis lawsuits..
On Dec. 4, 2023, the Supreme Court will hear arguments over a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.(AP.
This agreement aims to shield the Sackler family, Purdue Pharma's owners, from civil lawsuits linked to the opioid crisis..
If approved, the Purdue Pharma settlement would stand as one of the largest agreements by pharmaceutical entities, offering direct payments from a $750 million pool to victims, estimated between $3,500 and $48,000..
Notably, the Sackler family hasn't received payouts since Purdue Pharma's bankruptcy filing, although they accrued over $10 billion in the preceding decade, with a significant portion allocated for taxes...
You might be interested in
Explainer: How will the Supreme Court reshape US opioid epidemic relief?
03, Dec, 23The U.S. Supreme Court is set on Monday to hear arguments over the legality of a roughly $6 billion bankruptcy settlement involving Purdue Pharma, maker of the powerful and highly addictive pain medication OxyContin that played a key role in the country's opioid epidemic.
Purdue Pharma can protect Sackler owners in opioid bankruptcy
25, Jun, 23Bankrupt OxyContin maker Purdue Pharma can shield its owners, members of the wealthy Sackler family, from opioid lawsuits in exchange for a $6 billion contribution to the company's broader bankruptcy settlement, a U.S. appeals court ruled on Tuesday.
US Supreme Court set to review Purdue Pharma bankruptcy settlement
04, Dec, 23The U.S. Supreme Court on Monday is set to hear a challenge by President Joe Biden's administration to the legality of OxyContin maker Purdue Pharma's bankruptcy settlement, a deal that if approved would shield its wealthy Sackler family owners from lawsuits over their role in the country's opioid epidemic.